Citadel Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-10,700
| Closed | -$49K | – | 10295 |
|
|
2019
Q1 | $49K | Sell |
10,700
-800
| -7% | -$3.79K | ﹤0.01% | 8829 |
|
|
2018
Q4 | $40K | Sell |
11,500
-7,400
| -39% | -$51.4K | ﹤0.01% | 8545 |
|
|
2018
Q3 | $191K | Sell |
18,900
-56,400
| -75% | -$450K | ﹤0.01% | 8243 |
|
|
2018
Q2 | $545K | Buy |
75,300
+1,600
| +2% | +$11.2K | ﹤0.01% | 6229 |
|
|
2018
Q1 | $445K | Buy |
73,700
+26,900
| +57% | +$222K | ﹤0.01% | 6096 |
|
|
2017
Q4 | $450K | Buy |
46,800
+7,900
| +20% | +$51.7K | ﹤0.01% | 5805 |
|
|
2017
Q3 | $345K | Buy |
38,900
+20,900
| +116% | +$216K | ﹤0.01% | 5856 |
|
|
2017
Q2 | $228K | Sell |
18,000
-44,400
| -71% | -$525K | ﹤0.01% | 6365 |
|
|
2017
Q1 | $656K | Sell |
62,400
-41,400
| -40% | -$441K | ﹤0.01% | 4620 |
|
|
2016
Q4 | $955K | Buy |
103,800
+5,900
| +6% | +$66.7K | ﹤0.01% | 3918 |
|
|
2016
Q3 | $1.15M | Buy |
97,900
+58,100
| +146% | +$883K | ﹤0.01% | 3647 |
|
|
2016
Q2 | $515K | Sell |
39,800
-53,800
| -57% | -$784K | ﹤0.01% | 4441 |
|
|
2016
Q1 | $1.5M | Buy |
93,600
+39,900
| +74% | +$758K | ﹤0.01% | 2989 |
|
|
2015
Q4 | $1.54M | Buy |
53,700
+31,200
| +139% | +$864K | ﹤0.01% | 3045 |
|
|
2015
Q3 | $640K | Sell |
22,500
-23,700
| -51% | -$872K | ﹤0.01% | 4435 |
|
|
2015
Q2 | $1.66M | Sell |
46,200
-2,200
| -5% | -$68.5K | ﹤0.01% | 3281 |
|
|
2015
Q1 | $1.41M | Sell |
48,400
-31,200
| -39% | -$825K | ﹤0.01% | 3514 |
|
|
2014
Q4 | $1.68M | Sell |
79,600
-25,800
| -24% | -$510K | ﹤0.01% | 3129 |
|
|
2014
Q3 | $2.04M | Buy |
105,400
+87,200
| +479% | +$1.37M | ﹤0.01% | 2822 |
|
|
2014
Q2 | $284K | Buy |
+18,200
| New | +$294K | ﹤0.01% | 5129 |
|
Other funds holding INSY
WS
Citadel Advisors's INSY Position: Q2 2019 in Review
Citadel Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 101,329 shares — an estimated $468K sold.
Citadel Advisors first reported a position in INSY in Q3 2013 and held it in 18 quarters. The position peaked at $27.5M in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Citadel Advisors reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Citadel Advisors sold 101,329 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $468K.
- Citadel Advisors first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 18 quarters.
- Citadel Advisors's Insys Therapeutics, Inc. position peaked at $27.5M in Q3 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.